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Loss of function mutations in the 
 
autoimmune regulator
 
 (
 
Aire
 
) gene in autoimmune 
polyendocrinopathy-candidiasis-ectodermal dystrophy patients and mutant mice lead to 
autoimmune manifestations that segregate as a monogenic trait, but with wide variation in 
the spectrum of organs targeted. To investigate the cause of this variability, the 
 
Aire
 
 knockout 
mutation was backcrossed to mice of diverse genetic backgrounds. The background loci 
strongly influenced the pattern of organs that were targeted (stomach, eye, pancreas, liver, 
ovary, thyroid, and salivary gland) and the severity of the targeting (particularly strong on the 
nonobese diabetic background, but very mild on the C57BL/6 background). Autoantibodies 
mimicked the disease pattern, with oligoclonal reactivity to a few antigens that varied 
between Aire-deficient strains. Congenic analysis and a whole genome scan showed that 
autoimmunity to each organ had a distinctive pattern of genetic control and identified several 
regions that controlled the pattern of targeting, including the major histocompatibility 
complex and regions of 
 
Chr1
 
 and 
 
Chr3
 
 previously identified in controlling type 1 diabetes.
 
Most autoimmune diseases arise from a complex
interplay between environmental and genetic
factors, resulting in a break in immune self-
tolerance. Environmental factors have been
suspected from epidemiological evidence, in
particular because of the striking north/south
gradient in the susceptibility to autoimmune
diseases (1). Common autoimmune disorders
in humans such as type 1 diabetes (T1D),
rheumatoid arthritis, and systemic lupus ery-
thematosus reflect influences of a combination
of many genetic factors, and this complex genetic
picture in human patients has been supported by
results on animal models of autoimmune disease.
Mechanistic studies in the animal systems have
shown that the genetic variants conditioning
autoimmune disease act at several levels of
the immunoregulatory cascade that normally
enforces self-tolerance. For example, in the non-
obese diabetic (NOD) mouse model of T1D,
different susceptibility regions (termed 
 
Idd
 
loci) can affect the ability to clonally delete
self-reactive T cell precursors in the thymus
(2–5); the ability to present self-antigens and
select autoreactive T cells (6–8), peripheral tol-
erance, and the activity of T cells or molecules
with regulatory potential (9–12); or the aggres-
sivity of the lesion (13). Interestingly, congenic
or knockout studies in the NOD model have
revealed that the NOD genetic background
seems to predispose to autoimmune disease,
but that the autoimmune target can change
when some of the susceptibility loci are altered
(14–17).
In contrast, monogenic determinism char-
acterizes autoimmune polyendocrinopathy-
candidiasis-ectodermal dystrophy (APECED,
also known as APS-1; for review see reference
18), which displays autosomal recessive inher-
itance. The responsible genetic locus was iden-
tified by positional cloning as the gene encod-
ing autoimmune regulator (AIRE), a protein
with structural and functional features suggestive
of a transcription factor. Mutation of the gene
specifying the homologous protein in mice,
termed Aire, resulted in multiorgan inflamma-
tory infiltrates and autoantibodies (autoAbs) of
diverse specificities (19, 20). Exploration of
these mutant animals as a model of APECED
revealed that Aire exerts its antiautoimmunity
function primarily within thymic epithelial cells
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and that it does this by inducing the transcription of a large set
of genes encoding proteins considered to be tissue specific or
tissue restricted (20). In addition, 
 
Aire
 
 controls several genes
required for efficient presentation of these self-antigens in the
thymus, collectively resulting in poor clonal deletion of self-
reactive thymocytes (3, 21, 22). Thus, the working model is
that Aire promotes immunological tolerance to self by driving
the ectopic expression and presentation of many self-proteins
within the thymus and, thereby, the negative selection of de-
veloping self-reactive thymocytes (23, 24).
Although the disease is monogenic in transmission,
APECED patients show a variable range of pathological
manifestations, with each patient presenting a different con-
stellation of affected organs and autoAb specificities. Al-
though certain targets of the autoimmune attack are near
constant, such as the adrenal and parathyroid glands, other
manifestations are less frequently observed (e.g., thyroiditis
or T1D, which present in 2–12% of cases) (25, 26). 
 
Aire
 
knockout mice reproduced this variability, exhibiting a
broad range in the rapidity and severity of disease (19–21),
thus leading one to ponder the origin of this variability when
the very same mutation brings out different phenotypes in
individual mice or patients. The variability is unlikely to
stem from the mutations themselves because APECED pa-
Figure 1. The genetic background conditions the autoimmunity 
caused by Aire deficiency. (A) Lymphocytic infiltrates in Aire-deficient 
mice. Hematoxylin and eosin–stained liver (10 objective), salivary (10), 
stomach (20), and lung (10) sections from 20-wk-old sex-matched 
littermates that were Aire/ (top) and Aire/ (bottom) on an NOD (liver, 
salivary gland, and lung) or BALB/c background (stomach). (B) Pancreatic 
histology of NOD Aire/ mice at various stages of disease. (1) Perivascular 
infiltration (arrow), (2) patches of infiltrates (arrow) in exocrine pancreas, 
(3) massive infiltration in exocrine pancreas, and (4) complete destruction 
of exocrine pancreas, whereas the islets are spared (black arrows). (C) Percent 
incidence of disease in different organs in Aire/ mice on B6, BALB/c, 
NOD, and SJL backgrounds at 20 wk of age. Some of the NOD and SJL 
background mice were analyzed a few weeks earlier. n  total number 
of knockout mice analyzed. , no affected mice. Retina refers to retinal 
degeneration. Except for NOD background mice, in which sialitis was 
detected in 2/5 Aire/ controls, Aire-proficient littermates showed rare 
and mild pathology (2/11 lung infiltrates on the B6, 1/5 salivary gland in 
SJL, and 1/5 ovary in BALB/c backgrounds, respectively). (D) Growth curves 
of NOD.Aire/ and B6.Aire/ females. Open circles at 15 wk are the 
weights of groups of Aire/ littermates. (E) Survival of NOD.Aire/ females 
(open circles) and males (open squares; n  28 and 19, respectively) and 
B6. Aire/ mice (closed circles and squares; n  7 and 7, respectively).
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tients with the same mutation still show phenotypic variabil-
ity, and the cohorts of Aire-deficient mice all carry the same
mutation. One might invoke genetic variation, such as mod-
ifier loci affecting the course and targets of the disease; lim-
ited data are available, although an association of the HLA
complex with actual manifestations has been shown among
Finnish APECED patients (27). Alternatively, environmen-
tal triggers may precipitate the autoimmune attack against
particular organs. Finally, the onset of lesions in APECED
patients may be stochastic/chaotic, organ-specific pathology
resulting from a threshold of reactivity in the antigen recep-
tor repertoires of T and B lymphocytes.
To address this issue, we explored the influence of ge-
netic background variation on the autoimmune phenotype
of Aire-deficient mice. From the original knockout strain,
whose analysis had been performed on a mixed genetic
background, we crossed the 
 
Aire
 
-null mutation onto four
well-defined inbred backgrounds. The analysis revealed a
very strong interaction between the 
 
Aire
 
 mutation and back-
ground loci, controlling both the range of target organs and
the severity of the resulting autoimmune disease.
 
RESULTS
Genetic background alters the phenotype of autoimmunity 
in the absence of Aire
 
Aire-deficient mice spontaneously develop inflammatory in-
filtrates in multiple organs that increase with age and are ac-
companied by autoAbs against distinct structures in the same
organs (19, 20). The mice used for the original studies (19–
21) were of a mixed (129/Sv 
 

 
 C57BL/6) F2 genetic back-
ground, and targeted organs included the salivary gland,
ovary, prostate, eye, liver, and stomach, with variability in
the penetrance of each organ’s attack in different individuals.
To systematically test the influence of genetic background on
the autoimmune phenotype, we performed parallel back-
crosses of the 
 
Aire
 
 knockout mutation onto the C57BL/6J
(B6), NOD/LtJ (NOD), BALB/cJ (BALB/c), and SJL/J
backgrounds. These well-characterized inbred strains are
considered relatively resistant (B6 and BALB/c) or prone
(NOD and SJL) to autoimmune disease. After 8–10 genera-
tions of backcross, leaving 
 

 
1% residual heterozygosity, the
mice were intercrossed to generate homozygous experimen-
tal animals and littermate controls. Mice were aged to 20 wk,
the presence of inflammatory infiltrates was analyzed histo-
logically (Fig. 1), and the spectrum of autoAbs was revealed
by immunofluoresence on frozen tissue sections (Fig. 2).
The various genetic backgrounds had striking effects on
the diseases resulting from the Aire deficiency (Fig. 1, A and
B). First, the range of affected organs was quite different. For
instance, gastritis was constant in Balb.
 
Aire
 

 
 mice, but rare in
B6.
 
Aire
 

 
 mice; pancreatitis and thyroiditis were exclusive to
NOD.
 
Aire
 

 
 and SJL.
 
Aire
 

 
 mice. The distribution of autoAb
reactivities also showed clear strain distinctions that corre-
lated, albeit not completely, with strain-specific patterns of
organ infiltration (Fig. 2). These patterns of serological reac-
tivity were very reproducible; for example, the discrimina-
tion between different salivary glands by NOD.
 
Aire
 

 
 was
found with all these sera (more intense staining of the sublin-
Figure 2. Autoantibodies from Aire-deficient mice of different 
genetic backgrounds match the disease specificity. (A) Representative 
staining of frozen sections from retina, ovary, stomach, salivary, and pancreas 
(10) of a RAG-deficient mouse with sera from 10-wk-old Aire/ mice 
from different backgrounds, and an age- and sex- matched Aire/ mouse 
(B6 background, except for stomach section [BALB/c background]). P, parotid; 
Sl, sublingual gland; Sm, submandibular gland; Ex, exocrine pancreas; Is, 
pancreatic islets. (B) Summary of the presence of organ-specific autoAbs 
to the indicated organs in individual 10-wk-old Aire/ mice from different 
backgrounds. , trace staining.
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gual than the parotid or submandibular glands). This analysis
also revealed a new target organ, the exocrine pancreas, that
had not been observed in the original analysis of knockout
mice on the (B6 
 

 
 129) F2 background. Aire-deficient mice
on both NOD and SJL backgrounds were susceptible to
these pancreatic lesions; those on the BALB/c and B6 back-
grounds were resistant. Although an involvement of the
pancreas was not surprising given the well-known suscepti-
bility of NOD mice to T1D, the focus on exocrine cells was
unexpected. As was previously observed (19, 20) and illus-
trated again by the focal infiltrates in the liver or salivary
gland (Fig. 1 A), the lesions were highly localized within the
pancreas. According to the analysis of numerous sections,
they appeared to progress from an initial extravasation into
the perivascular connective tissue (Fig. 1 B, 1 and 2) to a
front of cell destruction that moved through the exocrine
lobe (Fig. 1 B, 3), ultimately leaving a wasteland of amor-
phous tissue with duct-like structures (Fig. 1 B, 4). Strik-
ingly, the damage largely spared the islets, and all of the
NOD.
 
Aire
 

 
 mice remained normoglycemic (not depicted).
This exocrine specificity was also manifest in the autoAbs,
which bound abundantly to the exocrine pancreas but not to
the islets (Fig. 2, bottom).
Second, the NOD and SJL genetic backgrounds not only
brought out new targets, as in the pancreas, but also resulted
in more frequent and severe infiltrates in general (Fig. 1
A) and a higher reactivity of serum autoAbs (Fig. 2). Along
with an increased frequency of disease in multiple organs,
NOD.
 
Aire
 

 
 mice were also prone to weight loss between 5
and 15 wk of age (Fig. 1 D). This runting seemed to cor-
relate best with the intensity of the pancreas or lung le-
sions and led to early lethality on homozygotes (79% of
NOD.
 
Aire
 

 
 mice died spontaneously or had to be killed be-
tween 6 and 14 wk of age). Pathological analysis strongly
suggests that the lung lesions, with generalized pneumoni-
tis, must be those that provoke the weight loss and lethal-
ity in NOD.
 
Aire
 

 
 mice. Anecdotal evidence indicates that
Balb.
 
Aire
 

 
 mice are largely free of this phenotype, whereas
SJL.
 
Aire
 

 
 appear susceptible.
To investigate the range and specificity of the autoAbs
elicited by the Aire deficiency in the various strains, we
probed immunoblots of extracts from several tissues with sera
from individual Aire-deficient mice on the NOD, B6, and
BALB/c backgrounds. As shown in Fig. 3, the autoAb speci-
ficities detected by these blots mirrored the histopathology.
Sera from NOD.
 
Aire
 

 
 mice showed the broadest reactivity,
with staining of every target tissue, and were the only sera
that bound to pancreas proteins. Sera from Balb.
 
Aire
 

 
 mice
exhibited near-constant reactivity against stomach antigens,
with patterns distinctly different from those of sera from
NOD.
 
Aire
 

 
 mice. At the other end of the spectrum, sera
from B6.
 
Aire
 

 
 mice showed only sporadic and weak reactivity
against salivary and gastric antigens. In all cases, these specific-
ities were absent in control Aire-sufficient littermates. The re-
sults presented in Fig. 3 also highlighted the oligoclonality of
the autoimmune response. Within each strain, sera from indi-
vidual Aire-deficient mice yielded discrete patterns, with only
a limited number of visible bands. The patterns were quite re-
producible from one mouse to the next, with frequently re-
curring bands. The banding patterns varied with the back-
grounds and, as better depicted in Fig. 3 B, the autoAb targets
were largely tissue specific. Thus, the genetic background
Figure 3. Stronger and different autoAbs in NOD.Aire/ than in 
other strains. (A) Each lane of the multiscreen immunoblot shows auto-
Abs in the serum from a 10- or 20-wk-old individual Aire / mouse () 
or WT littermate () on the NOD, B6, or BALB/c background immunoblotted 
with pancreatic, salivary, or gastric antigens. Anti–-actin antibody as a 
positive control is in the first lane of each membrane. (B) Higher resolution 
immunoblot of autoAb targets in different tissues with sera from three 
different mice.
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controls the general intensity of the autoAb response, as well
as the exact self-antigens targeted by serum autoAbs.
 
Genetic analysis of pancreatitis and gastritis
 
Next, we asked what modifier loci might underlie these
differences and how these regions might relate to regions
known to influence spontaneous autoimmune diseases. A
series of crosses between the two inbred backgrounds with
the most divergent phenotype, B6 and NOD, were per-
formed. This combination was also attractive because of the
panels of genotyping reagents, large body of data, and
strains of congenic mice accumulated from prior work in
many laboratories dissecting diabetes susceptibility loci in
this strain combination. We focused on the two phenotypes
that were most divergent between these two strains, pan-
creatitis and gastritis (Fig. 1 B), and analyzed the impact of
the Aire deficiency in several congenic lines and in an F2
intercross setting.
Overall, the MHC plays the major role in the genetic
determinism of autoimmune disease, and the H2
 
g7
 
 haplotype
from the NOD mouse is the principal element in diabetes
susceptibility, with its impact far outweighing that of any
other locus (28). We tested the relative roles of the MHC
and the rest of the genome by introducing the 
 
Aire
 
 knockout
mutation from NOD.
 
Aire
 

 
 and B6.
 
Aire
 

 
 mice onto a recip-
rocal congenic pair of strains, NOD.H2
 
b
 
 and B6.H2
 
g7
 
. For
clarity, we have left out the results from Aire-proficient lit-
termate controls, but all manifestations discussed below were
strictly dependent on the 
 
Aire-
 
null mutation (unpublished
data). For pancreatitis, a strong influence of the MHC was
detected with the NOD-based congenics: the presence of at
least one copy of the H2
 
g7
 
 haplotype, and preferably two,
was required (Fig. 4 A). On the other hand, H2
 
g7
 
 was not
sufficient because the same MHC haplotypes only led to in-
frequent disease when combined with B6 alleles at all other
loci, i.e., in the B6.H2
 
g7
 
 congenic (Fig. 4 B). The same con-
clusions were reached for autoAb production: the H2
 
g7
 
 hap-
lotype at the MHC was necessary on the NOD.
 
Aire
 

 
 back-
ground, but was not sufficient on the B6.
 
Aire
 

 
 background
(Fig. 4, A and B, bottom).
Outside the MHC, the strongest protection against dia-
betes in congenic mice is conferred by the 
 
Idd3
 
 and 
 
Idd5
 
regions on chromosomes 3 and 1, respectively. To test
whether these regions could also protect against pancreatitis
and gastritis on the NOD background, we backcrossed
NOD.
 
Aire
 

 
 mice to the NOD.
 
Idd3/Idd5
 
 double-congenic
line (29, 30). No clear effect of 
 
Idd5
 
 alone was observed (Fig.
4 C). A limited degree of protection was observed with the
b/b allele at 
 
Idd3 
 
(Fig. 4 D), but this was pronounced when
complemented by the b/b allele at 
 
Idd5
 
 (Fig. 4 E), pointing
to synergestic interactions between the loci. Overall, the
NOD MHC region is necessary but not sufficient, and other
diabetes susceptibility regions also influence the develop-
ment of pancreatitis in the absence of Aire.
Figure 4. Different NOD congenic intervals influence Aire-associated 
pancreatitis and gastritis. NOD.Aire/ and B6.Aire/ mice were inter-
crossed with a set of congenic mice with different MHC or Idd intervals. 
(A, B, F, and G) MHC (reciprocal on B6 and NOD backgrounds). (C and H) Idd5b 
on the NOD background. (D) Idd3b on the NOD background. (E and I) Idd3b 
on the NOD.Idd5b background. Note that all NOD.Idd3 mice also carried 
the B6 allele at Idd5. The resulting Aire-deficient homozygous animals, 
which shared a genetic background except for the indicated genotype at 
the congenic interval, were scored histologically for pancreatitis (A–E) and 
gastritis (F–I) at 20 wk of age. Each circle represents an individual Aire/ 
mouse. Statistical p-values were obtained with a Wilcoxon rank sum test. 
(A and B, bottom) Immunoblots from sera of animals of the indicated 
genotypes, probing pancreas extracts.
GENETIC CONTROL OF AIRE AUTOIMMUNITY | Jiang et al.810
Analysis of gastritis in these congenics revealed an effect
different from that observed for pancreatitis. The most obvi-
ous difference was the absence of MHC association on either
the NOD.Aire or B6.Aire backgrounds; animals were
equally prone to gastritis whatever their MHC haplotype
(Fig. 4, E and F). On the other hand, a protective effect of
the B6 alleles at the Idd3 interval was observed (Fig. 4, G and
H), as for pancreatitis.
In a parallel effort to broadly gauge the number and im-
portance of modifier loci that control organ targeting in Aire-
deficient mice, we also performed an intercross between
NOD.Aire and B6.Aire mice. As shown in Fig. 5 A, both
pancreatitis and gastritis were essentially absent in the F1 ani-
mals, indicating that susceptibility to these autoimmune man-
ifestations is recessive, a common situation with the genetics
of autoimmunity. These (B6  NOD) F1.Aire mice were
then intercrossed, and the resulting (B6  NOD) F2.Aire
animals, whose chromosomes contained random shuffles of
the B6 and NOD genomes, were then assayed at 15 wk of
age for infiltrates in various organs. As expected, only a minor
fraction of the animals presented with pancreatitis or gastritis
(Fig. 5 B and Table S1, available at http://www.jem.org/cgi/
content/full/jem.20050693/DC1). There was no difference
in incidence between genders. In addition, the two diseases
were not correlated, as most of the affected mice presented
with one or the other lesion and only one mouse with both.
Lung and liver infiltrates correlated somewhat, however. Sera
from these F2 mice were also tested by immunoblotting
against extracts from pancreas (Fig. 5 C). There was a close
correlation between the presence of antipancreas autoAbs and
of pancreatic infiltrates, as sera from most mice with aggres-
sive pancreatitis gave strong reactivity on the blots (although
there were exceptions). A genome-wide scan was then per-
formed on genomic DNA from 98 Aire/ F2 mice, geno-
typed by fluorogenic PCR for a set of 117 single nucleotide
polymorphism (SNP) markers distinguishing the NOD and
B6 genomes. The markers covered all 19 autosomes, with an
average spacing of 16 Mb. Tabulations of the complete
marker set and the genotyping results are shown in Table S2.
Results from trait/marker association (S-plus, R/qtl) (31) are
displayed in Fig. 6 and summarized in Table 1. For pancreati-
tis, the highest logarithm of the odds (LOD) score was ob-
served for markers on Chr 17, which was consistent with the
above-described effect of the MHC in the congenic analysis.
Regions on Chr3, 9, and 1 had fairly comparable LOD scores
in the “suggestive” range, the former and latter being consis-
tent with the role of Idd3 and Idd5 detected in the congenic
Figure 5. Pancreatitis and gastritis in intercrossed NOD.Aire/ and 
B6.Aire/ mice. (A) Pancreatitis and gastritis in Aire/ (B6  NOD) F1 
mice. (B) Aire/ (B6  NOD) F2 mice were generated by intercrossing F1 
parents, and the resulting mice were scored for disease. The biparametric 
plots show scores of individual mice for pancreatitis versus gastritis (left) 
and pancreatitis versus pneumonitis (right). (C) Antipancreas autoAbs 
were assayed by immunoblot in sera from (B6  NOD) F2 Aire/ mice. 
Each lane corresponds to an individual F2 mouse whose histological 
pancreatitis score is shown at the top.
Table I. Main associated regions
Chr Peak position Max LOD Susceptibility allele Model
Mb
Pancreatitis 1 49.89 2.24 NOD recessive
Pancreatitis 3 114.35 2.59 NOD additive
Pancreatitis 9 48.92 2.36 NOD additive
Pancreatitis 13 52.37 1.69 NOD additive
Pancreatitis 17 32.80 3.3 NOD additive
Gastritis 3 37.23 5.04 NOD additive
JEM VOL. 202, September 19, 2005 811
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mice. For gastritis, there was a conspicuous absence of any
peak on Chr 17, which was again consistent with the con-
genic results of Fig. 4, but there appeared a very striking link-
age on Chr 3. This finding, coupled with the congenic data,
suggests that gastritis is not under MHC control but primarily
controlled by a region on Chr3. No significant scores (P 
0.05 after connection) were obtained for antibody reactivity,
perhaps owing to the limited number of animals and to the
different subphenotypes present among the antibody reactiv-
ity patterns. Finally, salivary gland infiltration showed no evi-
dence of linkage to any region in this cohort of F2 mice (not
shown), as might be expected given that there was little
difference between the parental strains. Thus, the F2 analy-
sis confirmed that autoimmune attack of different organs in
Aire-deficient mice show distinct genetic influences.
DISCUSSION
This study assessed the effect of genetic variation among in-
bred mouse strains on the autoimmune phenotype provoked
by a defective Aire gene as a guide to understanding the root
of phenotypic variation between APECED patients. Quite
clearly, background genes have a strong influence on the
overall penetrance of the phenotype, which ranges from
fairly mild in B6.Aire mice to lethal in 90% of NOD.Aire
mice. Our results are consistent with preliminary observa-
tions showing a greater incidence of gastritis in Aire-defi-
cient mice on the BALB/c than on the B6 backgrounds
(32). We conclude by analogy that much of the phenotypic
variability between APECED patients with the same muta-
tion in the AIRE gene must reflect the influence of genetic
modifier elements. Because APECED is a fairly rare disease,
this contribution would be impossible to track on a genome-
wide basis in human patients. The rather mild disease in
B6.Aire mice also suggests that some unrecognized individ-
uals might exist, in which some elements of the diagnostic
triad (adrenal, parathyroid deficiency, and candidiasis) would
be missing because of strongly inhibitory background genes.
Indeed, recent clinical reports have described patients with
AIRE-null mutations and atypical clinical features that do
not include the complete triad (33, 34). In addition, the
higher prevalence of APECED cases in particular popula-
tions (such as Sardinians, Iranian Jews, and Finns) may de-
note a higher frequency of positively acting alleles in these
groups, beyond that of the AIRE mutations themselves. It
may be no coincidence that these APECED-prone popula-
tions are also particularly susceptible to T1D (e.g., Finland
and Sardinia); the genetic makeup of these groups, more
prone to autoimmunity, may render the severity and detect-
ability of APECED particularly high.
The variation in modifier loci influence the Aire-defi-
cient phenotype in two distinct ways. First, they modify the
range of the targeted organs and antigens. For example, the
BALB/c background brings out susceptibility to gastritis and
oophoritis but not pancreatitis, whereas the NOD and SJL
backgrounds bring out susceptibility to gastritis, oophoritis,
pneumonitis, and pancreatitis. The fluctuation in the range
of antigen targeting is illustrated most graphically by the
stomach autoantigens detected on protein blots or tissue sec-
tions; the stomach structures and molecular species recog-
nized by sera from Balb.Aire and NOD.Aire mice are
clearly different. Second, the genetic variation also deter-
mines the overall intensity of the autoimmune reaction:
there were more aggressive lesions and higher autoAb
production against all organs in NOD.Aire mice. It is cer-
tainly no coincidence that the NOD mouse, the most pop-
ular mouse model of autoimmune diabetes, would be the
most susceptible of the backgrounds tested. NOD mice are
known to have defects in the central induction of tolerance
by clonal deletion (2–5) and likely in peripheral immunoreg-
ulatory pathways as well, although the nature of the latter re-
mains to be established (4, 9, 11, 35). In theory, both levels
could contribute; two different deficiencies in thymic clonal
Figure 6. Different genetic regions are associated with pancreatitis 
and gastritis in Aire/ (B6  NOD) F2 mice. 98 Aire/ (B6  NOD) F2 
mice were tested histologically and genotyped across the entire genome 
(117 SNP markers distinguishing NOD and B6 genomes, displayed in chro-
mosomal order). The LOD score is shown for association with pancreatitis 
(top) and gastritis (bottom). A score of 2.96 corresponds to a genome-wide 
significance of P  0.05 (1,000 permutations). (right) Disease scores for 
animals grouped by genotype at the different markers are shown.
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deletion might synergize, or faulty peripheral immunoregu-
lation might further unveil autoreactive T cells that had been
improperly tolerized because of a lack of Aire in the thymus.
In this respect, it is noteworthy that the NOD background
does not broaden the range of protein targets as it intensifies
the degree of the autoimmune response. The number of
bands on stomach immunoblots is comparable in Balb.Aire
and NOD.Aire mice, but their intensities vary. This finding
might be more compatible with the second notion, that im-
munoregulatory defects in NOD mice support a better acti-
vation and amplification of autoreactive T cells that are al-
lowed to pass unscathed through the thymus because of the
Aire deficiency. Consistent with this idea, we have found in
another context that the mechanisms of central tolerance
(controlled by Aire) and of peripheral T regulatory cells
(controlled by FoxP3) are highly complementary (unpub-
lished data; Chen, Z., personal communication).
The location of the pancreatic autoimmunity in
NOD.Aire mice did come as a surprise. We had expected
that the Aire deficiency might accelerate the course of spon-
taneous diabetes in the NOD mouse, particularly because
the Ins-2 gene is one of the principal genes whose ectopic
transcription in the thymus is dependent on Aire (20). Yet,
not a single NOD.Aire mouse ever became diabetic, and
true insulitis was quite rare in NOD.Aire or F2 mice. Part
of the explanation may lie in the fact that NOD diabetes is
very susceptible to environmental influences (36), and one
might propose that the raging exocrine pancreatitis, which
occurs quite early, might inhibit the development of insulitis
and diabetes. The pancreatic lesions also resemble, in their
early phases, those described in aged NOD.B10H2b con-
genic mice (14). Might there be, in NOD mice, a spontane-
ous tendency to inflammation in the perivascular tissues of
the pancreas, which then focuses on either the endocrine or
exocrine components as a function of tolerance defects re-
sulting from MHC or Aire variation?
It is also interesting to note that the phenotype of au-
toimmune exocrine pancreatitis has been suggested in sev-
eral clinical studies of APECED patients (37, 38). Many
APECED patients have chronic malabsorption, and the pan-
creatitis phenotype of the Aire-deficient mice supports the
notion that this process may explain part of the malabsorp-
tion syndrome in these subjects.
The pneumonitis and peribronchial infiltrates observed
in the NOD.Aire- mice were also absent in the original de-
scriptions. It is interesting to note that the NOD genetic
background is associated with the development of promi-
nent bronchial-associated lymph tissue (BALT) in aged ani-
mals (39). The prominence in BALT was not seen in age-
matched Aire-proficient controls in our study because they
were analyzed at younger ages (20 wk vs. 1 yr). This predis-
position to BALT formation, however, may explain why
this phenotype is brought out in the NOD.Aire/ mice.
In all mouse strains examined, the autoimmunity was
pauciclonal, focused on a rather limited range of targets with
quite reproducible patterns from one mouse to the next. In-
cidentally, the backcrossing onto inbred backgounds reduced
the interindividual variability in the profiles of immunoreac-
tivity observed with the original Aire-deficient (B6  129)
F2 cohort (unpublished data; Garibyan, L., personal commu-
nication). One wonders why such a limited array of antigens
is targeted, given that the absence of Aire modifies the ec-
topic thymic expression of several hundred genes (20, 40).
Quite likely, the ability of these self-antigens to be taken up
by antigen-presenting cells processed to “presentable” pep-
tides for MHC binding restricts the range of potential tar-
gets, much as MHC alleles do in classic autoimmune diseases.
It is also possible that dominant autoimmune attacks mask
others, much as the exocrine pancreatitis in NOD.Aire/
mice seems to impinge on islet pathology. This implies,
then, that even when the immune system is confronted with
defective central tolerance to a large number of self-antigens,
the constraints on MHC specificity, antigen handling, pe-
ripheral tolerance and autoimmune activation can sharply
limit the potential damage.
The very nature of the genomic regions implicated in
controlling the Aire-negative phenotype in the very concor-
dant analyses in congenic and F2 animals was also somewhat
surprising. We had expected to uncover a dominant role for
the MHC in targeting the affected organs given its strong as-
sociation with many autoimmune models. The MHC region
did have a clear effect on pancreatitis, with the strongest im-
pact in the congenic analysis, but it was not much greater than
were the contributions of other regions on Chr3 and Chr9 in
the F2 linkage analysis (although the relative contributions of
the regions may be somewhat approximate in this instance
given the number of mice involved). For gastritis, there was
no sign of association with the MHC in either the congenic
or F2 Aire-deficient mice. Thus, the influence of MHC al-
leles, when present, was far from being as overwhelming as it
usually is in the susceptibility to classic autoimmune diseases
like T1D. This contribution is consistent with the reports of
minor influence of the HLA region on the range of affections
in APECED patients (27, 41). NOD-derived alleles in the
Idd3 interval on Chr3 were implicated in several instances,
predominantly for gastritis, but also for pancreatitis. This ef-
fect may represent the contribution of the NOD genome to
subvert peripheral tolerance, as discussed above, and may in-
volve the same variant genes that underpin susceptibility to
T1D in this strain. This diversity of influences is compatible
with the fact that essentially no correlation was found be-
tween the autoimmune attacks on different organs in the F2
cohort. One might speculate that these organ-specific influ-
ences represent polymorphisms in actual self-antigens or the
ability of specific organs to shed antigens in a manner that ac-
tivates an autoimmune response, much as developmentally
programmed apoptosis in pancreatic islet cells initiates the ac-
tivation of islet-specific autoimmunity (42). Perhaps related,
several congenic or knockout variants of NOD mice are pro-
tected from diabetes but develop alternate autoimmune dis-
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eases such as thyroiditis (15), autoimmune neuropathy (16), or
autoimmune biliary disease (17).
There is also an interesting parallel with the range of au-
toimmune diseases provoked by neonatal thymectomy or
Aire deficiency. The neonatal thymectomy model is thought
to reflect perturbations in the population of CD25 T regu-
latory cells. Neonatally thymectomized BALB/c animals are
particularly prone to gastritis (43), which is similar to what
we observe in BALB/c.Aire/ mice. This suggests that
some of the mechanisms that focus autoimmunity to particu-
lar organs may be shared in the two models. Previous work
comparing neonatal thymectomy in the BALB/c with the
B6 (which are resistant to gastritis) backgrounds has mapped
the control of gastritis to chromosome 4 (44), which is dif-
ferent from the chromosomal associations found here. This
might indicate that NOD and BALB/c susceptibility to gas-
tritis have different determinism and targets, which is consis-
tent with the different reactivity profiles on the immuno-
blots. More generally, however, that autoimmune attack on
different target organs is determined by specific genetic re-
gions may be a theme common to defects in central toler-
ance, as in Aire-deficiency, and to defects in regulatory cells,
as in the neonatal thymectomy models (44, 45).
In conclusion, these experiments show that the genetic
background strongly conditions the manifestations of the de-
fective self-tolerance resulting from a primary mutation in
the Aire gene. In human populations, as in the inbred mice
studied here, genetic polymorphism likely sets the range of
organs for autoimmune attack and controls the severity of
the disease that ensues. In this sense, the distinctions between
monogenic and the typical polygenic autoimmune diseases
become blurred.
MATERIALS AND METHODS
Mice. C57BL/6J, NOD/LtJ, BALB/cJ, SJL/J, NOD.H2b, and B6.H2g7
mice were obtained from the Jackson Laboratory, and NOD.Idd3B6.Idd5B10
mice (46) were obtained from Taconic Farms. All mice were housed and
bred under specific pathogen-free conditions at the Harvard Medical School
Center for Animal Resources and Comparative Medicine (Institutional An-
imal Care and Use Committee protocol 2954). The Aire knockout muta-
tion, originally generated on a mixed (129/Sv  C57BL/6) F2 genetic
background (20), was backcrossed onto the C57BL/6J (B6), NOD/LtJ
(NOD), BALB/cJ (BALB/c), and SJL/J backgrounds for more than eight
generations and intercrossed once for analysis. NOD.H2b.Aire/ and
B6.H2g7.Aire/ strains were generated by crossing NOD.Aire/ mice
with NOD.H2b (Jackson Laboratory) and B6.Aire/ mice with B6.H2g7
mice, respectively. NOD.Idd3/5.Aire/ strains were derived by backcross-
ing NOD.Aire/ mice with NOD.Idd3B6.Idd5B10 mice, selecting for Idd3
and Idd5 alleles before intercrossing. For the F1 and F2 analyses,
NOD.Aire/ males were bred with B6.Aire/ females (both backcrossed
for more than eight generations), and the resulting (B6  NOD) F1.Aire/
or Aire/ mice were intercrossed to generate cohorts of (B6  NOD)
F2.Aire/ mice. Mice were genotyped for the Aire mutation by PCR of
tail DNA as described previously (20). The MHC haplotype was deter-
mined by allele-specific PCR for MHC-II Ab (5-TCTAGAATTCA-
CAGCGACATGGGCGAGC-3 and 5-TCTAGAATTCCGTAGT-
TGTGTCTGCACA-3) or by staining peripheral blood lymphocytes with
anti–I-Ab (AF6-120.1; BD Biosciences) and anti–I-Ag7 (10–2.16). Idd3,
Idd5.1, and Idd5.2 alleles were typed by PCR using the following primer
pairs: D3Mit21, D1Mit74, and D1Mit132 (available from the Mouse Ge-
nome Informatics Database).
Histopathology. Tissues were fixed in buffered 10% formalin and embed-
ded with paraffin. Tissue sections were stained with hematoxylin and eosin
and scored in a blinded fashion for lymphocytic infiltrates. In general, 0, 0.5,
1, 2, 3, and 4 indicate no, trace, mild, moderate, or severe lymphocytic in-
filtration, and complete destruction, respectively. For retinal degeneration,
1  lesion present, but less than half of the photoreceptor layer lost; 2 
more than half of the photoreceptor layer lost; 3  entire photoreceptor
layer lost without or with mild outer nuclear layer attack; and 4  the en-
tire photoreceptor layer and most of the outer nuclear layer destroyed. For
immunohistology, 5-	m frozen sections of eye, ovary, salivary, stomach,
and pancreas were prepared from a 7-wk-old NOD.RAG-deficient mouse
(to avoid Igs in the organs), incubated with 1:100 dilutions of sera, and
counterstained with FITC-conjugated goat anti–mouse IgG (Jackson Im-
munoResearch Laboratories).
Western blotting. Pancreas, salivary, and stomach tissue were homoge-
nized on ice in a buffer containing 50 mM Tris, pH 8.0, 150 mM NaCl, 1%
CHAPS, and a protease inhibitor cocktail (Roche Diagnostic). The ho-
mogenates were centrifuged at 13,000 revolutions per minute for 10 min, and
the supernatants were mixed with a double volume of sample buffer (62.5
mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, and 5% -mercaptoethanol).
The extracts were separated by 10% SDS-PAGE gel and electrophoretically
transferred onto a polyvinylidene fluoride membrane (Bio-Rad Labortato-
ries). The membranes were blocked with TBST (25 Mm Tris-HCl, pH 7.6,
150 mM NaCl, and 0.1% Tween 20) containing 5% nonfat milk for 1 h and
assembled in a Mini-PROTEAN II Multiscreen apparatus (Bio-Rad Labor-
tatories) and incubated overnight with 1:500 dilution of sera. After washing
five times with TBST, the bound antibodies were reacted with horseradish
peroxidase–conjugated donkey anti–mouse IgG (1:3,000; Jackson Immu-
noResearch Laboratories) for 1 h and revealed with an enhanced chemilu-
minescence reagent (Pierce Chemical Co.) and autoradiography.
Genetic analysis. Genomic DNA was isolated from tail tips of 98 (B6 
NOD) F2Aire/ mice by phenol-chloroform extraction and genotyped for
SNP markers distinguishing B6 and NOD alleles, as previously described
(5). Genetic analyses were performed with R/qtl and customized S-plus
scripts for simple marker/trait association testing of dominant/additive/re-
cessive effects (5). Experiment-wise p-values were established by permuta-
tion testing (1,000 permutations in R/qtl or S-Plus).
Online supplemental material. Table S1 shows histological score of
(B6  NOD) F2 Aire/ mice. Table S2 shows the position and the trait/
marker association score for each SNP tested in (B6  NOD) F2 Aire/
mice. Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20050693/DC1.
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